To achieve a successful advancement in personalized CAR therapeutics for the treatment of cancers, Creative Biolabs provides CellRapeutics™ CAR Clinical Trials service. Since the CAR therapeutics holds great promise to improving cancer patients’ health, we strive to move these novel therapeutics into clinical trials based on our years of experience in CAR technology, uncompromising quality standards and unbeatable timelines. For each project, once the preclinical animal models study for safety and efficacy test is complete and ready for clinical trials, Creative Biolabs assembles a strong team with experienced Ph.D level scientists and clinicians, well trained technicians, responsible project managers just in order to deliver the most suitable service according to your budget, timeline, and specific requirements.
To speed up the development of CAR therapeutics in clinical trials, we provide one-stop, full spectrum service to deliver the most efficient and economic outcomes.
Service & Solutions
• Review of preclinical testing
• Study design and protocol writing
• Ethics & Regulatory
• Project management
• Physician management
• Clinical operations
• Patient enrollment
• Patient treatment
• Patient follow-up
• Data management
• Study summary
• Biostatistics & medical writing
For any technical issues or products/services related questions, please leave your information below. Our team will contact you soon.
Nanoparticle Tiny Tech for Programming T Cells: A novel technology to increase the efficiency and value of your CAR-T therapy project.LEARN MORE
Angiotensin-converting Enzyme 2 (ACE2)-CHO Cell Line Model for COVID-19: Helps researchers to further study the interaction between the receptor ACE2 and the COVID-19 virus.LEARN MORE
TRAC-CAR-T Cell Development with CRISPR/Cas9 Technology: A novel technology to build more powerful CAR-T cells.LEARN MORE